Price Alert

Amedisys Inc. (AMED)

NASDAQ: AMED · Real-Time Price · USD

100.99

0.01 (0.01%)

At close: Aug 14, 2025, 3:59 PM

0.01% (1D)

Bid	99.01
Market Cap	3.32B
Revenue (ttm)	2.4B
Net Income (ttm)	149.69M
EPS (ttm)	2.57
PE Ratio (ttm)	39.295719844357976
Forward PE	19.53
Analyst	Hold
Dividends	n/a

Ask	102
Volume	1,037,740
Avg. Volume (20D)	517,900
Open	101.00
Previous Close	100.98
Day's Range	100.93 - 101.02
52-Week Range	82.15 - 101.02
Beta	0.90
Ex-Dividend Date	n/a

About AMED

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol AMED

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AMED stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Amedisys has released their quartely earnings on Jul 29, 2025:

Revenue of $621.86M exceeds estimates by $9.93M, with 5.19% YoY growth.

EPS of 1.54 exceeds estimates by 0.18, with 16.67% YoY growth.

Next Earnings Release

Amedisys Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

8 months ago

+4.67%

Amedisys shares are trading higher after the compa... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors

AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it f...

1 month ago · zacks.com

Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 month ago · fool.com

Amedisys (AMED) Q2 Revenue Tops 5%

1 month ago · zacks.com

Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street ...

1 month ago · zacks.com

Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates

Amedisys (AMED) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.32 per share a year ago.